- Home
- MGYR vs IMUX Comparison
MGYR vs IMUX Comparison
Compare MGYR & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGYR
- IMUX
- Stock Information
- Founded
- MGYR 1922
- IMUX 2016
- Country
- MGYR United States
- IMUX United States
- Employees
- MGYR N/A
- IMUX N/A
- Industry
- MGYR Savings Institutions
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- MGYR Finance
- IMUX Health Care
- Exchange
- MGYR Nasdaq
- IMUX Nasdaq
- Market Cap
- MGYR 94.1M
- IMUX 102.2M
- IPO Year
- MGYR 2006
- IMUX N/A
- Fundamental
- Price
- MGYR $13.98
- IMUX $1.20
- Analyst Decision
- MGYR
- IMUX Strong Buy
- Analyst Count
- MGYR 0
- IMUX 7
- Target Price
- MGYR N/A
- IMUX $12.67
- AVG Volume (30 Days)
- MGYR 2.9K
- IMUX 548.2K
- Earning Date
- MGYR 04-22-2025
- IMUX 05-07-2025
- Dividend Yield
- MGYR 1.79%
- IMUX N/A
- EPS Growth
- MGYR 10.61
- IMUX N/A
- EPS
- MGYR 1.30
- IMUX N/A
- Revenue
- MGYR $32,424,000.00
- IMUX N/A
- Revenue This Year
- MGYR N/A
- IMUX N/A
- Revenue Next Year
- MGYR N/A
- IMUX N/A
- P/E Ratio
- MGYR $10.81
- IMUX N/A
- Revenue Growth
- MGYR 7.24
- IMUX N/A
- 52 Week Low
- MGYR $10.66
- IMUX $0.92
- 52 Week High
- MGYR $14.90
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- MGYR 40.34
- IMUX 55.66
- Support Level
- MGYR $14.14
- IMUX $1.18
- Resistance Level
- MGYR $14.09
- IMUX $1.35
- Average True Range (ATR)
- MGYR 0.24
- IMUX 0.06
- MACD
- MGYR -0.04
- IMUX 0.00
- Stochastic Oscillator
- MGYR 7.89
- IMUX 48.28
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.